Globus Medical (GMED) Competitors

Globus Medical (NYSE:GMED) and IDEXX Laboratories (NASDAQ:IDXX) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, community ranking, analyst recommendations, risk and institutional ownership.

Which has stronger valuation and earnings, GMED or IDXX?

IDEXX Laboratories has higher revenue and earnings than Globus Medical. IDEXX Laboratories is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globus Medical	$2.52B	3.88	$122.87M	$0.75	94.87
IDEXX Laboratories	$3.90B	9.80	$887.87M	$10.67	44.18

Do insiders and institutionals have more ownership in GMED or IDXX?

95.2% of Globus Medical shares are held by institutional investors. Comparatively, 87.8% of IDEXX Laboratories shares are held by institutional investors. 18.5% of Globus Medical shares are held by company insiders. Comparatively, 1.0% of IDEXX Laboratories shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community believe in GMED or IDXX?

Globus Medical received 35 more outperform votes than IDEXX Laboratories when rated by MarketBeat users. However, 71.73% of users gave IDEXX Laboratories an outperform vote while only 67.33% of users gave Globus Medical an outperform vote.

Company	Underperform	Outperform
Globus Medical	Outperform Votes 573 67.33%	Underperform Votes 278 32.67%
IDEXX Laboratories	Outperform Votes 538 71.73%	Underperform Votes 212 28.27%

Is GMED or IDXX more profitable?

IDEXX Laboratories has a net margin of 22.78% compared to Globus Medical's net margin of 4.09%. IDEXX Laboratories' return on equity of 55.82% beat Globus Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Globus Medical	4.09%	10.83%	8.63%
IDEXX Laboratories	22.78%	55.82%	26.48%

Does the media refer more to GMED or IDXX?

In the previous week, IDEXX Laboratories had 14 more articles in the media than Globus Medical. MarketBeat recorded 32 mentions for IDEXX Laboratories and 18 mentions for Globus Medical. Globus Medical's average media sentiment score of 1.27 beat IDEXX Laboratories' score of 1.15 indicating that Globus Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Globus Medical	16 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IDEXX Laboratories	20 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, GMED or IDXX?

Globus Medical has a beta of 1.28, meaning that its share price is 28% more volatile than the S&P 500. Comparatively, IDEXX Laboratories has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500.

Do analysts recommend GMED or IDXX?

Globus Medical currently has a consensus target price of $96.91, indicating a potential upside of 36.20%. IDEXX Laboratories has a consensus target price of $523.75, indicating a potential upside of 11.11%. Given Globus Medical's higher probable upside, equities research analysts clearly believe Globus Medical is more favorable than IDEXX Laboratories.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globus Medical	0 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.75
IDEXX Laboratories	0 Sell rating(s)	3 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.78

Summary

IDEXX Laboratories beats Globus Medical on 12 of the 19 factors compared between the two stocks.